Adrian Towse is the Director of the Office of Health Economics (OHE). A Visiting Fellow at LSE Adrian is also a Senior Visiting Fellow at the Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford. Adrian has also been a Visiting Professor at the Department of Economics and Related Studies, University of York. For ten years he served as a Non-Executive Director of the Oxford Radcliffe NHS Trust (now the Oxford University Hospitals NHS Trust), one of the UK’s largest research and teaching hospitals. He served at various times as chair of its Governance Committee, chair of its Audit Committee, and chair of its Relocation Board (overseeing the closure of the Radcliffe Infirmary site and the opening of the West Wing and the Cancer Centre). Adrian is currently President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) the largest international association of health economists and health outcomes researchers. His areas of research include: incentives for R&D for new products to tackle antimicrobial resistance; economic issues that affect both R&D for and access to treatments for diseases prevalent in middle and low income countries; the use of ‘risk-sharing’ arrangements between health care payers and pharmaceutical companies; the economics of stratified/personalised medicine for health care payers and the pharmaceutical industry; and the use of HTA by payers to assess value.